QA: Tango Therapeutics Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001819133_2023_Tango_Therapeutics_Inc.pdf

Logs

Graph

Absolute values for 0001819133, Tango Therapeutics Inc.

  xvar xval
0 AssetsCurrent 375,272,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 10,884,000
3 remainder_Assets 50,314,000
4 LiabilitiesCurrent 55,545,000
5 LiabilitiesNoncurrent 131,449,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 30,025,000
9 ResearchAndDevelopmentExpense 105,906,000
10 remainder_Expenses 54,000
11 remainder_Revenues 24,860,000
12 remainder_NetIncome 2,949,000
13 remainder_ComprehensiveNetIncome -2,940,000
  yvar yval
0 Assets 436,470,000
1 Liabilities 186,994,000
2 Expenses 135,985,000
3 Revenues 24,860,000
4 StockholdersEquity 249,476,000
5 NetIncome -108,176,000
6 ComprehensiveNetIncome -109,646,000
7 BaseVar 395,099,000
8 EconomicCapitalRatio 1.02

Edgar->Model Mapping

Feature Distribution

Change over Time